APO Research
Talk to an analyst

APO RESEARCH · REPORT

Helicobacter Pylori Diagnostics

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.

Selected research

Market Analysis & Forecast

Global Helicobacter Pylori Diagnostics Market Analysis and Forecast 2026-2032

1 January 2026198 pages

Choose your research edition.

Industry ResearchHelicobacter Pylori Diagnostics Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Helicobacter Pylori Diagnostics Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Helicobacter Pylori Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Helicobacter Pylori Diagnostics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Helicobacter Pylori Diagnostics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.

Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.

Report Includes

Read the full market overview

This report presents an overview of global market for Helicobacter Pylori Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Helicobacter Pylori Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Helicobacter Pylori Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Helicobacter Pylori Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Helicobacter Pylori Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Helicobacter Pylori Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Helicobacter Pylori Diagnostics Segment by Company

Sekisui Diagnostics

F. Hoffmann-La Roche

Medline Industries

Meridian Bioscience

Bio-Rad Laboratories

Thermo Fisher Scientific

Alpha Laboratories

EKF Diagnostics

Quidel

Halyard Health

Cardinal Health

Beckman Coulter

Agilent Technologies

Coris BioConcept

Helicobacter Pylori Diagnostics Segment by Type

Invasive Techniques

Non-invasive Techniques

Helicobacter Pylori Diagnostics Segment by Application

Hospitals and Clinics

Diagnostic Laboratories

Others

Helicobacter Pylori Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Helicobacter Pylori Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Helicobacter Pylori Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Helicobacter Pylori Diagnostics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Invasive Techniques Major Player Table 3. Non-invasive Techniques Major Player Table 4. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals and Clinics Major Player Table 6. Diagnostic Laboratories Major Player Table 7. Others Major Player Table 8. Helicobacter Pylori Diagnostics Industry Trends Table 9. Helicobacter Pylori Diagnostics Industry Drivers Table 10. Helicobacter Pylori Diagnostics Industry Opportunities and Challenges Table 11. Helicobacter Pylori Diagnostics Industry Restraints Table 12. Global Helicobacter Pylori Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Helicobacter Pylori Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Helicobacter Pylori Diagnostics Market Share by Region (2021-2026) Table 15. Global Helicobacter Pylori Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Helicobacter Pylori Diagnostics Market Share by Region (2027-2032) Table 17. Global Helicobacter Pylori Diagnostics Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Helicobacter Pylori Diagnostics Revenue Market Share by Players (2021-2026) Table 19. Global Helicobacter Pylori Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Helicobacter Pylori Diagnostics Key Players Headquarters & Area Served Table 21. Global Helicobacter Pylori Diagnostics Players, Product Type & Application Table 22. Global Helicobacter Pylori Diagnostics Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Helicobacter Pylori Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Helicobacter Pylori Diagnostics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Helicobacter Pylori Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Helicobacter Pylori Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2021-2026) Table 29. Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2027-2032) Table 30. Global Helicobacter Pylori Diagnostics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Helicobacter Pylori Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Helicobacter Pylori Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2021-2026) Table 34. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2027-2032) Table 35. Sekisui Diagnostics Company Information Table 36. Sekisui Diagnostics Business Overview Table 37. Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio Table 39. Sekisui Diagnostics Recent Development Table 40. F. Hoffmann-La Roche Company Information Table 41. F. Hoffmann-La Roche Business Overview Table 42. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio Table 44. F. Hoffmann-La Roche Recent Development Table 45. Medline Industries Company Information Table 46. Medline Industries Business Overview Table 47. Medline Industries Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Medline Industries Helicobacter Pylori Diagnostics Product Portfolio Table 49. Medline Industries Recent Development Table 50. Meridian Bioscience Company Information Table 51. Meridian Bioscience Business Overview Table 52. Meridian Bioscience Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio Table 54. Meridian Bioscience Recent Development Table 55. Bio-Rad Laboratories Company Information Table 56. Bio-Rad Laboratories Business Overview Table 57. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio Table 59. Bio-Rad Laboratories Recent Development Table 60. Thermo Fisher Scientific Company Information Table 61. Thermo Fisher Scientific Business Overview Table 62. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio Table 64. Thermo Fisher Scientific Recent Development Table 65. Alpha Laboratories Company Information Table 66. Alpha Laboratories Business Overview Table 67. Alpha Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio Table 69. Alpha Laboratories Recent Development Table 70. EKF Diagnostics Company Information Table 71. EKF Diagnostics Business Overview Table 72. EKF Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio Table 74. EKF Diagnostics Recent Development Table 75. Quidel Company Information Table 76. Quidel Business Overview Table 77. Quidel Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Quidel Helicobacter Pylori Diagnostics Product Portfolio Table 79. Quidel Recent Development Table 80. Halyard Health Company Information Table 81. Halyard Health Business Overview Table 82. Halyard Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Halyard Health Helicobacter Pylori Diagnostics Product Portfolio Table 84. Halyard Health Recent Development Table 85. Cardinal Health Company Information Table 86. Cardinal Health Business Overview Table 87. Cardinal Health Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio Table 89. Cardinal Health Recent Development Table 90. Beckman Coulter Company Information Table 91. Beckman Coulter Business Overview Table 92. Beckman Coulter Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio Table 94. Beckman Coulter Recent Development Table 95. Agilent Technologies Company Information Table 96. Agilent Technologies Business Overview Table 97. Agilent Technologies Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio Table 99. Agilent Technologies Recent Development Table 100. Coris BioConcept Company Information Table 101. Coris BioConcept Business Overview Table 102. Coris BioConcept Helicobacter Pylori Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio Table 104. Coris BioConcept Recent Development Table 105. North America Helicobacter Pylori Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Helicobacter Pylori Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Helicobacter Pylori Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Helicobacter Pylori Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Helicobacter Pylori Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Helicobacter Pylori Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Helicobacter Pylori Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 112. Europe Helicobacter Pylori Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Helicobacter Pylori Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Helicobacter Pylori Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Helicobacter Pylori Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Helicobacter Pylori Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Helicobacter Pylori Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 118. Europe Helicobacter Pylori Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 119. China Helicobacter Pylori Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 120. China Helicobacter Pylori Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 121. China Helicobacter Pylori Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 122. China Helicobacter Pylori Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Helicobacter Pylori Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 124. Asia Helicobacter Pylori Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 125. Asia Helicobacter Pylori Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 126. Asia Helicobacter Pylori Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Helicobacter Pylori Diagnostics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Helicobacter Pylori Diagnostics Revenue by Region (US$ Million) & (2021-2026) Table 129. Asia Helicobacter Pylori Diagnostics Revenue by Region (US$ Million) & (2027-2032) Table 130. SAMEA Helicobacter Pylori Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 131. SAMEA Helicobacter Pylori Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 132. SAMEA Helicobacter Pylori Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 133. SAMEA Helicobacter Pylori Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 134. SAMEA Helicobacter Pylori Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. SAMEA Helicobacter Pylori Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 136. SAMEA Helicobacter Pylori Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Helicobacter Pylori Diagnostics Image Figure 2. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Helicobacter Pylori Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Invasive Techniques Image Figure 5. Non-invasive Techniques Image Figure 6. Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Helicobacter Pylori Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals and Clinics Image Figure 9. Diagnostic Laboratories Image Figure 10. Others Image Figure 11. Global Helicobacter Pylori Diagnostics Market Size (US$ Million) & (2021-2032) Figure 12. Global Helicobacter Pylori Diagnostics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Helicobacter Pylori Diagnostics Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Helicobacter Pylori Diagnostics Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Helicobacter Pylori Diagnostics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Helicobacter Pylori Diagnostics Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2021-2032) Figure 19. Global Helicobacter Pylori Diagnostics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2021-2032) Figure 22. North America Helicobacter Pylori Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Helicobacter Pylori Diagnostics Revenue Share by Type (2021-2032) Figure 24. North America Helicobacter Pylori Diagnostics Revenue Share by Application (2021-2032) Figure 25. North America Helicobacter Pylori Diagnostics Revenue Share by Country (2021-2032) Figure 26. United States Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Helicobacter Pylori Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Helicobacter Pylori Diagnostics Revenue Share by Type (2021-2032) Figure 31. Europe Helicobacter Pylori Diagnostics Revenue Share by Application (2021-2032) Figure 32. Europe Helicobacter Pylori Diagnostics Revenue Share by Country (2021-2032) Figure 33. Germany Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Helicobacter Pylori Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Helicobacter Pylori Diagnostics Revenue Share by Type (2021-2032) Figure 43. China Helicobacter Pylori Diagnostics Revenue Share by Application (2021-2032) Figure 44. Asia Helicobacter Pylori Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Helicobacter Pylori Diagnostics Revenue Share by Type (2021-2032) Figure 46. Asia Helicobacter Pylori Diagnostics Revenue Share by Application (2021-2032) Figure 47. Asia Helicobacter Pylori Diagnostics Revenue Share by Region (2021-2032) Figure 48. Japan Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Helicobacter Pylori Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Helicobacter Pylori Diagnostics Revenue Share by Type (2021-2032) Figure 56. SAMEA Helicobacter Pylori Diagnostics Revenue Share by Application (2021-2032) Figure 57. SAMEA Helicobacter Pylori Diagnostics Revenue Share by Country (2021-2032) Figure 58. Brazil Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Helicobacter Pylori Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Invasive Techniques
  • Non-invasive Techniques
Applications
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others
Companies covered
  • Sekisui Diagnostics
  • F. Hoffmann-La Roche
  • Medline Industries
  • Meridian Bioscience
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Alpha Laboratories
  • EKF Diagnostics
  • Quidel
  • Halyard Health
  • Cardinal Health
  • Beckman Coulter
  • Agilent Technologies
  • Coris BioConcept

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Helicobacter Pylori Diagnostics Market by Type
  3. 1.2.1 Global Helicobacter Pylori Diagnostics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Invasive Techniques
  5. 1.2.3 Non-invasive Techniques
  6. 1.3 Helicobacter Pylori Diagnostics Market by Application
  7. 1.3.1 Global Helicobacter Pylori Diagnostics Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals and Clinics
  9. 1.3.3 Diagnostic Laboratories
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Helicobacter Pylori Diagnostics Market Dynamics
  1. 2.1 Helicobacter Pylori Diagnostics Industry Trends
  2. 2.2 Helicobacter Pylori Diagnostics Industry Drivers
  3. 2.3 Helicobacter Pylori Diagnostics Industry Opportunities and Challenges
  4. 2.4 Helicobacter Pylori Diagnostics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Helicobacter Pylori Diagnostics Market Perspective (2021-2032)
  2. 3.2 Global Helicobacter Pylori Diagnostics Growth Trends by Region
  3. 3.2.1 Global Helicobacter Pylori Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Helicobacter Pylori Diagnostics Market Size by Region (2021-2026)
  5. 3.2.3 Global Helicobacter Pylori Diagnostics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Helicobacter Pylori Diagnostics Revenue by Players
  2. 4.1.1 Global Helicobacter Pylori Diagnostics Revenue by Players (2021-2026)
  3. 4.1.2 Global Helicobacter Pylori Diagnostics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Helicobacter Pylori Diagnostics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Helicobacter Pylori Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Helicobacter Pylori Diagnostics Key Players Headquarters & Area Served
  7. 4.4 Global Helicobacter Pylori Diagnostics Players, Product Type & Application
  8. 4.5 Global Helicobacter Pylori Diagnostics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Helicobacter Pylori Diagnostics Market CR5 and HHI
  11. 4.6.3 2025 Helicobacter Pylori Diagnostics Tier 1, Tier 2, and Tier 3
5 Helicobacter Pylori Diagnostics Market Size by Type
  1. 5.1 Global Helicobacter Pylori Diagnostics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Helicobacter Pylori Diagnostics Revenue by Type (2021-2032)
  3. 5.3 Global Helicobacter Pylori Diagnostics Revenue Market Share by Type (2021-2032)
6 Helicobacter Pylori Diagnostics Market Size by Application
  1. 6.1 Global Helicobacter Pylori Diagnostics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Helicobacter Pylori Diagnostics Revenue by Application (2021-2032)
  3. 6.3 Global Helicobacter Pylori Diagnostics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sekisui Diagnostics
  2. 7.1.1 Sekisui Diagnostics Company Information
  3. 7.1.2 Sekisui Diagnostics Business Overview
  4. 7.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
  6. 7.1.5 Sekisui Diagnostics Recent Developments
  7. 7.2 F. Hoffmann-La Roche
  8. 7.2.1 F. Hoffmann-La Roche Company Information
  9. 7.2.2 F. Hoffmann-La Roche Business Overview
  10. 7.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
  12. 7.2.5 F. Hoffmann-La Roche Recent Developments
  13. 7.3 Medline Industries
  14. 7.3.1 Medline Industries Company Information
  15. 7.3.2 Medline Industries Business Overview
  16. 7.3.3 Medline Industries Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
  18. 7.3.5 Medline Industries Recent Developments
  19. 7.4 Meridian Bioscience
  20. 7.4.1 Meridian Bioscience Company Information
  21. 7.4.2 Meridian Bioscience Business Overview
  22. 7.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
  24. 7.4.5 Meridian Bioscience Recent Developments
  25. 7.5 Bio-Rad Laboratories
  26. 7.5.1 Bio-Rad Laboratories Company Information
  27. 7.5.2 Bio-Rad Laboratories Business Overview
  28. 7.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
  30. 7.5.5 Bio-Rad Laboratories Recent Developments
  31. 7.6 Thermo Fisher Scientific
  32. 7.6.1 Thermo Fisher Scientific Company Information
  33. 7.6.2 Thermo Fisher Scientific Business Overview
  34. 7.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
  36. 7.6.5 Thermo Fisher Scientific Recent Developments
  37. 7.7 Alpha Laboratories
  38. 7.7.1 Alpha Laboratories Company Information
  39. 7.7.2 Alpha Laboratories Business Overview
  40. 7.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
  42. 7.7.5 Alpha Laboratories Recent Developments
  43. 7.8 EKF Diagnostics
  44. 7.8.1 EKF Diagnostics Company Information
  45. 7.8.2 EKF Diagnostics Business Overview
  46. 7.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
  48. 7.8.5 EKF Diagnostics Recent Developments
  49. 7.9 Quidel
  50. 7.9.1 Quidel Company Information
  51. 7.9.2 Quidel Business Overview
  52. 7.9.3 Quidel Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Quidel Helicobacter Pylori Diagnostics Product Portfolio
  54. 7.9.5 Quidel Recent Developments
  55. 7.10 Halyard Health
  56. 7.10.1 Halyard Health Company Information
  57. 7.10.2 Halyard Health Business Overview
  58. 7.10.3 Halyard Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
  60. 7.10.5 Halyard Health Recent Developments
  61. 7.11 Cardinal Health
  62. 7.11.1 Cardinal Health Company Information
  63. 7.11.2 Cardinal Health Business Overview
  64. 7.11.3 Cardinal Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
  66. 7.11.5 Cardinal Health Recent Developments
  67. 7.12 Beckman Coulter
  68. 7.12.1 Beckman Coulter Company Information
  69. 7.12.2 Beckman Coulter Business Overview
  70. 7.12.3 Beckman Coulter Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
  72. 7.12.5 Beckman Coulter Recent Developments
  73. 7.13 Agilent Technologies
  74. 7.13.1 Agilent Technologies Company Information
  75. 7.13.2 Agilent Technologies Business Overview
  76. 7.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
  78. 7.13.5 Agilent Technologies Recent Developments
  79. 7.14 Coris BioConcept
  80. 7.14.1 Coris BioConcept Company Information
  81. 7.14.2 Coris BioConcept Business Overview
  82. 7.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
  84. 7.14.5 Coris BioConcept Recent Developments
8 North America
  1. 8.1 North America Helicobacter Pylori Diagnostics Revenue (2021-2032)
  2. 8.2 North America Helicobacter Pylori Diagnostics Revenue by Type (2021-2032)
  3. 8.2.1 North America Helicobacter Pylori Diagnostics Revenue by Type (2021-2026)
  4. 8.2.2 North America Helicobacter Pylori Diagnostics Revenue by Type (2027-2032)
  5. 8.3 North America Helicobacter Pylori Diagnostics Revenue Share by Type (2021-2032)
  6. 8.4 North America Helicobacter Pylori Diagnostics Revenue by Application (2021-2032)
  7. 8.4.1 North America Helicobacter Pylori Diagnostics Revenue by Application (2021-2026)
  8. 8.4.2 North America Helicobacter Pylori Diagnostics Revenue by Application (2027-2032)
  9. 8.5 North America Helicobacter Pylori Diagnostics Revenue Share by Application (2021-2032)
  10. 8.6 North America Helicobacter Pylori Diagnostics Revenue by Country
  11. 8.6.1 North America Helicobacter Pylori Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Helicobacter Pylori Diagnostics Revenue by Country (2021-2026)
  13. 8.6.3 North America Helicobacter Pylori Diagnostics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Helicobacter Pylori Diagnostics Revenue (2021-2032)
  2. 9.2 Europe Helicobacter Pylori Diagnostics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Helicobacter Pylori Diagnostics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Helicobacter Pylori Diagnostics Revenue by Type (2027-2032)
  5. 9.3 Europe Helicobacter Pylori Diagnostics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Helicobacter Pylori Diagnostics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Helicobacter Pylori Diagnostics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Helicobacter Pylori Diagnostics Revenue by Application (2027-2032)
  9. 9.5 Europe Helicobacter Pylori Diagnostics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Helicobacter Pylori Diagnostics Revenue by Country
  11. 9.6.1 Europe Helicobacter Pylori Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Helicobacter Pylori Diagnostics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Helicobacter Pylori Diagnostics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Helicobacter Pylori Diagnostics Revenue (2021-2032)
  2. 10.2 China Helicobacter Pylori Diagnostics Revenue by Type (2021-2032)
  3. 10.2.1 China Helicobacter Pylori Diagnostics Revenue by Type (2021-2026)
  4. 10.2.2 China Helicobacter Pylori Diagnostics Revenue by Type (2027-2032)
  5. 10.3 China Helicobacter Pylori Diagnostics Revenue Share by Type (2021-2032)
  6. 10.4 China Helicobacter Pylori Diagnostics Revenue by Application (2021-2032)
  7. 10.4.1 China Helicobacter Pylori Diagnostics Revenue by Application (2021-2026)
  8. 10.4.2 China Helicobacter Pylori Diagnostics Revenue by Application (2027-2032)
  9. 10.5 China Helicobacter Pylori Diagnostics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Helicobacter Pylori Diagnostics Revenue (2021-2032)
  2. 11.2 Asia Helicobacter Pylori Diagnostics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Helicobacter Pylori Diagnostics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Helicobacter Pylori Diagnostics Revenue by Type (2027-2032)
  5. 11.3 Asia Helicobacter Pylori Diagnostics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Helicobacter Pylori Diagnostics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Helicobacter Pylori Diagnostics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Helicobacter Pylori Diagnostics Revenue by Application (2027-2032)
  9. 11.5 Asia Helicobacter Pylori Diagnostics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Helicobacter Pylori Diagnostics Revenue by Country
  11. 11.6.1 Asia Helicobacter Pylori Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Helicobacter Pylori Diagnostics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Helicobacter Pylori Diagnostics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Helicobacter Pylori Diagnostics Revenue (2021-2032)
  2. 12.2 SAMEA Helicobacter Pylori Diagnostics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Helicobacter Pylori Diagnostics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Helicobacter Pylori Diagnostics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Helicobacter Pylori Diagnostics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Helicobacter Pylori Diagnostics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Helicobacter Pylori Diagnostics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Helicobacter Pylori Diagnostics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Helicobacter Pylori Diagnostics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Helicobacter Pylori Diagnostics Revenue by Country
  11. 12.6.1 SAMEA Helicobacter Pylori Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Helicobacter Pylori Diagnostics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Helicobacter Pylori Diagnostics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst